Co-stimulation of LPAR1 and S1PR1/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases
Authors:
Open Access
- 14 June 2018
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 9 (1) , 161
Abstract
One of the major obstacles facing stem cell therapy is the limited number of functional stem cells available after transplantation due to the harsh microenvironment surrounding the damaged tissue. The aim of this study was to delineate the mechanistic involvement of lysophosphatidic acid receptors (LPARs) and sphingosine-1-phosphate receptors (S1PRs) in the regulation of anti-stress and transplantation efficacy of stem cells. Human adipose-derived mesenchymal stem cells (hADMSCs) were treated with chemical toxin or ethanol to induce cell stress. Lysophosphatidic acid (LPA) and/or sphingosine-1-phosphate (S1P) were co-treated to examine their protective effects and mechanisms on stem cell damage. Acute liver failure and alcoholic liver disease murine models were also established to test the transplantation efficacy of hADMSCs with or without LPA/S1P pre-incubation. Co-stimulation of LPAR1 by LPA and S1PR1/3 by S1P synergistically enhanced the anti-stress ability of hADMSCs induced by chemical or ethanol incubation in vitro. Downstream pathways involved in this process included the Gi protein (but not the G12/13 proteins), the RAS/ERK pathway, and the PI3K/Akt pathway. Upon cell injury, the nuclear translocation of nuclear factor-kappa B (NF-κB) was promoted to facilitate the activation of downstream pro-inflammatory gene transcription, which was ameliorated by co-treatment with LPA and/or S1P. Increased secretion of interleukin (IL)-10 from stem cells by LPA and/or S1P seemed to be one of the major protective mechanisms since blocking IL-10 expression significantly aggravated stress-induced cell damage. In a drug-induced acute liver failure model and a chronic alcoholic liver disease model, pre-conditioning with LPA and/or S1P significantly enhanced the survival ratio and the therapeutic efficacy of hADMSCs in mice, including ameliorating histological damage, oxidative stress, inflammation, fibrosis, lipid metabolism dysfunction, and enhancing alcohol metabolizing enzyme activity. Importantly, supplementing LPA and/or S1P did not alter the basic characteristics of the hADMSCs nor induce tumour formation after cell transplantation. Co-use of LPA and S1P represents a novel and safe strategy to enhance stem cell transplantation efficacy for future drug- and alcoholic-related liver disease therapies.Keywords
Funding Information
- Major Science and Technology Projects of Guangdong Province (2015B020225005)
- Basic Research Fund of Shenzhen City (JCYJ20150402111430633)
- National Natural Science Foundation of China (31300813)
This publication has 46 references indexed in Scilit:
- Lysophosphatidic acid protects against acetaminophen-induced acute liver injuryExperimental & Molecular Medicine, 2017
- Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic ModelJournal of the American Society of Nephrology, 2017
- Role of Osteoblast Gi Signaling in Age-Related Bone Loss in Female MiceEndocrinology, 2017
- Stem cell–derived models to improve mechanistic understanding and prediction of human drug‐induced liver injuryHepatology, 2016
- Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trialHepatology, 2016
- Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivoProceedings of the National Academy of Sciences, 2016
- Paracrine Engineering of Human Explant-Derived Cardiac Stem Cells to Over-Express Stromal-Cell Derived Factor 1α Enhances Myocardial RepairStem Cells, 2016
- Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure modelScientific Reports, 2015
- Lysophosphatidic acid rescues bone mesenchymal stem cells from hydrogen peroxide-induced apoptosisApoptosis, 2015
- Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4+ very small embryonic-like stem cellsLeukemia, 2009